Illumina revenue rose to $1.13 billion in the third quarter of 2026
Illumina, Inc. reported financial results for the third quarter of 2026, with revenue of $1.13 billion, up 4.2% from the same period last year. Earnings exceeded guidance due to healthy clinical demand and robust NovaSeq X placements.
Key points
- In the third quarter of 2026, the company recognized an IEEPA tariff refund benefit that reduced the cost of revenue by $79 million.
- The company cannot provide a reconciliation of forward-looking non-GAAP financial measures to GAAP measures because it is unable to predict with reasonable certainty items such as acquisition-related costs, fair value adjustments, and pending litigation outcomes.
Financial results and operating expenses
In the third quarter of 2026, the company recognized an IEEPA tariff refund benefit that reduced the cost of revenue by $79 million. It also recorded a $37 million reduction in revenue for expected customer credits related to these tariffs. Transformational initiative costs this year primarily involved ERP system upgrade implementation.
Revenue by quarter, $B
Sector context: 89 covered companies in Information Technology reported a median revenue change of +20.6% YoY in their latest filings.
Shareholder structure and risks
The company cannot provide a reconciliation of forward-looking non-GAAP financial measures to GAAP measures because it is unable to predict with reasonable certainty items such as acquisition-related costs, fair value adjustments, and pending litigation outcomes.
What to watch
Investors should review the quarterly report to verify the final impact of IEEPA tariff refunds on the income statement.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Illumina
A notification in your browser or on your phone when we publish about Illumina. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
